THE CHINWAGY BUZZ · FIRST VERIFIED WORD

Bristol Myers Squibb and Sarah Cannon expand strategic oncology research collaboration

WHAT CHINWAGY KNOWS

The collaboration
is confirmed.

Bristol Myers Squibb and Sarah Cannon Research Institute expanded a strategic collaboration using SCRI’s Accelero clinical-trial delivery model to accelerate patient enrollment and broaden access to oncology trials.

Current status
Official collaboration
Known availability
Started 2025-11-12; the official source does not state an end date.
Place
Nashville, United States
Source checked
September 13, 2026

SHARE OR FOLLOW THE BUZZ

Keep it moving.

Share the permanent Chinwagy profile, download a branded social card or save the story so its next update stays within reach.

FOLLOW THE STORY

More details will move this intelligence into the right Chinwagy destination.